[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% +15%
6 Months: XX% +18%
1 Year: XX% +34%
1-Year High: XXX% on 2025-08-16
1-Year Low: XX% on 2025-04-04
Most Supportive Themes
- Eli Lilly's Obesity and Diabetes Pipeline: (45%) Positive sentiment surrounds Eli Lilly's advancements in the obesity and diabetes treatment market, particularly with Mounjaro and Zepbound.
- TrumpRx and Potential Drug Price Deals: (30%) News of potential drug price deals with the Trump administration, specifically the TrumpRx platform, is generating positive sentiment for LLY.
- Positive Analyst Ratings and Growth Projections: (15%) Many analysts have set high target prices for LLY, with strong growth projections based on the performance of weight management and GLP-1 drugs.
Most Critical Themes
- Competition and Market Dynamics: (5%) Concerns exist regarding the intensifying competition in the GLP-1 market, particularly from Novo Nordisk (NVO) and potential compounders.
- Legal and Regulatory Risks: (5%) The ongoing lawsuit between LLY and NKTR, along with potential regulatory pressures, poses a risk.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| News | XX | X% | ||||
| X | X% | XX | X% | XX | X% | |
| TikTok | XX | X% | XXX | X% | XXX | X% |
| X | XXX | X% | XXXXX | X% | XXXXX | X% |
| YouTube | XX | X% | XXX | X% | XXX | X% |
| Total | XXXXX | X% | XXXXX | X% | XXX | X% |